COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study

Israel Krieger; Galit Erez; Orly Weinstein; Arnon Dov Cohen; Dana Tzur Bitan

doi:10.1007/s10803-021-05187-2

COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study

Israel Krieger, Galit Erez, Orly Weinstein, Arnon Dov Cohen, Dana Tzur Bitan

Research output: Contribution to journal › Article › peer-review

Abstract

In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p <.001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.

Original language	English
Pages (from-to)	789-794
Number of pages	6
Journal	Journal of Autism and Developmental Disorders
Volume	53
Issue number	2
DOIs	https://doi.org/10.1007/s10803-021-05187-2
State	Published - Feb 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

ASD
Autism Spectrum Disorder
COVID-19
Infection
Morbidity
Population-based

ASJC Scopus subject areas

Developmental and Educational Psychology

Access to Document

10.1007/s10803-021-05187-2

Cite this

@article{92ab1ce210c54180b6b5dd64f5627757,

title = "COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study",

abstract = "In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p <.001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.",

keywords = "ASD, Autism Spectrum Disorder, COVID-19, Infection, Morbidity, Population-based",

author = "Israel Krieger and Galit Erez and Orly Weinstein and Cohen, {Arnon Dov} and {Tzur Bitan}, Dana",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2023",

month = feb,

doi = "10.1007/s10803-021-05187-2",

language = "English",

volume = "53",

pages = "789--794",

journal = "Journal of Autism and Developmental Disorders",

issn = "0162-3257",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder

T2 - A Matched Controlled Population-Based Study

AU - Krieger, Israel

AU - Erez, Galit

AU - Weinstein, Orly

AU - Cohen, Arnon Dov

AU - Tzur Bitan, Dana

PY - 2023/2

Y1 - 2023/2

N2 - In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p <.001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.

AB - In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40–60 (OR = 2.05, 95%CI 1.33–3.15, p <.001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14–5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks.

KW - ASD

KW - Autism Spectrum Disorder

KW - COVID-19

KW - Infection

KW - Morbidity

KW - Population-based

UR - http://www.scopus.com/inward/record.url?scp=85109683211&partnerID=8YFLogxK

U2 - 10.1007/s10803-021-05187-2

DO - 10.1007/s10803-021-05187-2

M3 - Article

C2 - 34240292

AN - SCOPUS:85109683211

SN - 0162-3257

VL - 53

SP - 789

EP - 794

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

IS - 2

ER -

COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this